ZMYND8 is a negative regulator of ferroptosis in BCSCs
ZMYND8 Protects Breast Cancer Stem Cells against Oxidative Stress and Ferroptosis through Activation of NRF2 Overall design: Parental and ZMYND8 knockout MDA-MB-231 mammospheres were subjected to NRF2 ChIP-seq.